These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 34302903)
1. Time of onset and duration of post-COVID-19 acute telogen effluvium. Abrantes TF; Artounian KA; Falsey R; Simão JCL; Vañó-Galván S; Ferreira SB; Davis TL; Ridenour W; Goren A; Tosti A; Wambier CG J Am Acad Dermatol; 2021 Oct; 85(4):975-976. PubMed ID: 34302903 [No Abstract] [Full Text] [Related]
2. COVID-19 infection is a major cause of acute telogen effluvium. Sharquie KE; Jabbar RI Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470 [TBL] [Abstract][Full Text] [Related]
3. A case of telogen effluvium followed by alopecia areata after SARS-CoV-2 infection. Kageyama R; Ito T; Nakazawa S; Shimauchi T; Fujiyama T; Honda T J Dermatol; 2023 Jan; 50(1):e32-e34. PubMed ID: 36205724 [No Abstract] [Full Text] [Related]
4. Characteristics of telogen effluvium in COVID-19 in western Iran (2020). Babaei K; Kavoussi H; Rezaei M; Kavoussi R An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265 [TBL] [Abstract][Full Text] [Related]
5. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia. Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium? Koç Yıldırım S; Erbağcı E; Demirel Öğüt N J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647 [TBL] [Abstract][Full Text] [Related]
7. The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies. Weng CT; Wei KC; Yang CC Influenza Other Respir Viruses; 2024 Jul; 18(7):e13356. PubMed ID: 39057605 [No Abstract] [Full Text] [Related]
8. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss. Aryanian Z; Balighi K; Hatami P; Afshar ZM; Mohandesi NA Dermatol Ther; 2022 Jun; 35(6):e15433. PubMed ID: 35266262 [TBL] [Abstract][Full Text] [Related]
13. The role of autologous micrografts injection from the scalp tissue in the treatment of COVID-19 associated telogen effluvium: Clinical and trichoscopic evaluation. Hawwam SA; Ismail M; Elhawary EE Dermatol Ther; 2022 Jul; 35(7):e15545. PubMed ID: 35486375 [TBL] [Abstract][Full Text] [Related]
14. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies. Gentile P Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012383 [TBL] [Abstract][Full Text] [Related]
15. Acute telogen effluvium associated with SARS-CoV-2 infection. Domínguez-Santás M; Haya-Martínez L; Fernández-Nieto D; Jiménez-Cauhé J; Suárez-Valle A; Díaz-Guimaraens B Aust J Gen Pract; 2020 Aug; 49():. PubMed ID: 33051638 [TBL] [Abstract][Full Text] [Related]
16. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience. Rizzetto G; Diotallevi F; Campanati A; Radi G; Bianchelli T; Molinelli E; Mazzanti S; Offidani A Dermatol Ther; 2021 Jan; 34(1):e14547. PubMed ID: 33190397 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of QR678 Neo Shome D; Kapoor R; Surana M; Vadera S; Shah R J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139 [TBL] [Abstract][Full Text] [Related]
18. Platelet-Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID-19 Infection: A Case Series. İşlek A; Karaaslan E; Şimşek S; Merve Çetin F J Cosmet Dermatol; 2022 Feb; 21(2):590-594. PubMed ID: 34965004 [TBL] [Abstract][Full Text] [Related]
19. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management. Ohyama M; Matsudo K; Fujita T J Dermatol; 2022 Oct; 49(10):939-947. PubMed ID: 35633047 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]